Eric Jonasch
0000-0003-0943-2806
6 papers found
Refreshing results…
Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study
Systemic Therapy Development in Von Hippel–Lindau Disease: An Outsized Contribution from an Orphan Disease
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Summary from the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research
Missing publications? Search for publications with a matching author name.